BioIntelliSense is a healthcare technology company that was founded in 2019 by Dr. James Mault. It provides health monitoring through its wearable technology and clinical intelligence solutions. It is committed to making physiologic monitoring accessible to every patient.
The company develops medical-grade wearable biosensors and a clinical intelligence platform for continuous patient monitoring and the maintenance of Electronic Medical Records (EMR) of the patient.
Its primary products are FDA-cleared BioSticker™ and BioButton® wearable devices. These compact and easy-to-set sensors stick to the patient’s chest and continuously track multiple vital signs for in-facility and at-home patients. The devices can track heart rate, respiratory rate, skin temperature, activity levels, sleep patterns, gait, and symptomatic events.
The system can capture up to 1,440 biometric measurements per day as it uses continuous data collection instead of intermittent spot checks. The company also developed a pulse oximetry (SpO₂) sensor that received FDA approval to solve accuracy problems that occur because of skin color and movement.
BioIntelliSense operates a data-as-a-service business model, which enables secure wearable data collection through its analytics platform. The platform provides dashboards, alerts, and reporting tools that work together with electronic health record systems to enable remote patient monitoring. Its clients include hospitals, health systems, and provider groups because they need to manage patients who have chronic conditions or who need post-discharge care.
The BioIntelliSense model shifts care from episodic measurement to proactive, data-driven clinical oversight. The company markets itself as a remote monitoring solution that uses both regulated wearable devices and continuous data analytics.